Arik V Marcell1, Keith Plowden, Shameeka M Bowman. 1. Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of Maryland, School of Medicine, Baltimore, MD 21201, USA. amarcell@peds.umaryland.edu
Abstract
BACKGROUND: Male hormonal contraceptive methods (HCM) are in Phase I clinical trials in the USA. International studies report that adults have positive attitudes regarding male HCM, but little is known about US minority young peoples' attitudes--a population that experiences high unintended pregnancy rates. METHODS: Thirty urban African American young persons [50% males; mean age = 18.8 (SD = 2.5)] participated in semi-structured interviews to explore attitudes regarding male HCM. Data were independently analysed by two researchers according to qualitative research methodology, including transcript coding for content, categorization of codes, performance of content analysis for theme development, and corroboration of findings by a third researcher. RESULTS: The data revealed five major themes that can facilitate and/or hinder male HCM adoption: (1) impact of reversing roles in HCM use; (2) men's lack of involvement in health care; (3) men's reliability to use HCM effectively; (4) perceived responsibility of men who use HCM; and (5) men's apprehension to use new medicines. Overall, participants had positive impressions about male HCM (67% male; 67% female) and female partner trust of males' use was high (85%), as were males' intentions (60%). CONCLUSIONS: Findings provide a foundation for clinical interventions including: (1) increasing males' involvement in reproductive health; (2) helping males to overcome apprehensions about male HCM safety; and (3) standardizing male HCM education in the clinical setting. Future research efforts should examine whether study findings hold for other populations.
BACKGROUND: Male hormonal contraceptive methods (HCM) are in Phase I clinical trials in the USA. International studies report that adults have positive attitudes regarding male HCM, but little is known about US minority young peoples' attitudes--a population that experiences high unintended pregnancy rates. METHODS: Thirty urban African American young persons [50% males; mean age = 18.8 (SD = 2.5)] participated in semi-structured interviews to explore attitudes regarding male HCM. Data were independently analysed by two researchers according to qualitative research methodology, including transcript coding for content, categorization of codes, performance of content analysis for theme development, and corroboration of findings by a third researcher. RESULTS: The data revealed five major themes that can facilitate and/or hinder male HCM adoption: (1) impact of reversing roles in HCM use; (2) men's lack of involvement in health care; (3) men's reliability to use HCM effectively; (4) perceived responsibility of men who use HCM; and (5) men's apprehension to use new medicines. Overall, participants had positive impressions about male HCM (67% male; 67% female) and female partner trust of males' use was high (85%), as were males' intentions (60%). CONCLUSIONS: Findings provide a foundation for clinical interventions including: (1) increasing males' involvement in reproductive health; (2) helping males to overcome apprehensions about male HCM safety; and (3) standardizing male HCM education in the clinical setting. Future research efforts should examine whether study findings hold for other populations.
Authors: Arik V Marcell; Jonathan D Klein; Ismor Fischer; Marjorie J Allan; Patricia K Kokotailo Journal: J Adolesc Health Date: 2002-01 Impact factor: 5.012
Authors: Shumei S Sun; Christine M Schubert; William Cameron Chumlea; Alex F Roche; Howard E Kulin; Peter A Lee; John H Himes; Alan S Ryan Journal: Pediatrics Date: 2002-11 Impact factor: 7.124
Authors: R A Anderson; Z M Van Der Spuy; O A Dada; S K Tregoning; P M Zinn; O A Adeniji; T A Fakoya; K B Smith; D T Baird Journal: Hum Reprod Date: 2002-11 Impact factor: 6.918
Authors: Gareth C Weston; Michelle L Schlipalius; Meabh Ni Bhuinneain; Beverley J Vollenhoven Journal: Med J Aust Date: 2002-03-04 Impact factor: 7.738
Authors: Robert I McLachlan; Liza O'Donnell; Peter G Stanton; Georgia Balourdos; Mark Frydenberg; David M de Kretser; David M Robertson Journal: J Clin Endocrinol Metab Date: 2002-02 Impact factor: 5.958
Authors: Tamar Jacobsohn; Brian T Nguyen; Jill E Brown; Arthi Thirumalai; Michael Massone; Stephanie T Page; Christina Wang; Jeffrey Kroopnick; Diana L Blithe Journal: Contraception Date: 2022-05-10 Impact factor: 3.051
Authors: Brian T Nguyen; Anthony L Brown; Felica Jones; Loretta Jones; Mellissa Withers; Katharine M Ciesielski; Jennifer M Franks; Christina Wang Journal: Contraception Date: 2021-06-09 Impact factor: 3.051